Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes

Diabetes Care. 2005 Jun;28(6):1316-20. doi: 10.2337/diacare.28.6.1316.

Abstract

Objective: The aim of this study was to investigate the effect of caffeine (in doses equivalent to normal daily ingestion) on rates and severity of hypoglycemia in patients with long-standing type 1 diabetes to determine the relationship between caffeine, autonomic function, and hypoglycemia.

Research design and methods: Using a double-blinded randomized study, we investigated the effect of caffeine versus placebo in 19 patients with long-standing type 1 diabetes using continuous glucose sensing technology and simultaneous assessment of autonomic function using Holter monitoring.

Results: Caffeine reduced the duration of nocturnal hypoglycemia with a mean duration of 49 minutes (range 0-235) versus 132 (0-468) minutes (P = 0.035). The reduction in duration of nighttime hypoglycemia was due to a decline in the number of episodes of moderate hypoglycemia at the expense of mild hypoglycemic episodes (P = 0.04). There was no overall correlation between reduced heart rate variability (a marker of autonomic dysfunction) and hypoglycemic events (r(s) = 0.12, P = 0.62).

Conclusions: Our results suggest that caffeine is associated with a significant reduction in nocturnal hypoglycemia. The reduction in nocturnal hypoglycemia was not linked to the concomitant rise in parasympathetic activity associated with caffeine.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism*
  • Blood Pressure
  • Caffeine / pharmacology*
  • Central Nervous System Stimulants / pharmacology
  • Diabetes Mellitus, Type 1 / blood*
  • Double-Blind Method
  • Female
  • Heart Rate
  • Humans
  • Hypoglycemia / epidemiology*
  • Hypoglycemia / prevention & control
  • Male
  • Middle Aged
  • Monitoring, Ambulatory
  • Placebos

Substances

  • Blood Glucose
  • Central Nervous System Stimulants
  • Placebos
  • Caffeine